tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

INCY Stock Latest News

Knight Therapeutics announces launch of Minjuvi in Mexico
The FlyKnight Therapeutics announces launch of Minjuvi in Mexico
9d ago
INCY
Incyte price target lowered to $65 from $69 at Morgan Stanley
PremiumThe Fly
Incyte price target lowered to $65 from $69 at Morgan Stanley
11d ago
INCY
Incyte’s Hold Rating: Balancing Pipeline Challenges and Established Product Valuation
PremiumRatings
Incyte’s Hold Rating: Balancing Pipeline Challenges and Established Product Valuation
11d ago
INCY
Monday.com, Incyte, Lucid, Bloom, EQT: Trending by Analysts
PremiumWeekend Updates
Monday.com, Incyte, Lucid, Bloom, EQT: Trending by Analysts
13d ago
BE
EQT
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
15d ago
PLX
SLS
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
16d ago
PLX
ANNX
Incyte’s Povorcitinib Shows Promise but Faces Competitive and Market Challenges, Leading to Hold Rating
Premium
Ratings
Incyte’s Povorcitinib Shows Promise but Faces Competitive and Market Challenges, Leading to Hold Rating
17d ago
INCY
Coinbase initiated, Block upgraded: Wall Street’s top analyst calls
Premium
The Fly
Coinbase initiated, Block upgraded: Wall Street’s top analyst calls
17d ago
BE
RL
Incyte price target lowered to $72 from $74 at Truist
PremiumThe Fly
Incyte price target lowered to $72 from $74 at Truist
17d ago
INCY
Incyte’s Stock Downgraded to Sell Amid Disappointing Drug Data and Market Challenges
PremiumRatings
Incyte’s Stock Downgraded to Sell Amid Disappointing Drug Data and Market Challenges
17d ago
INCY
Guggenheim downgrades Incyte on povorcitinib’s ‘somewhat underwhelming’ profile
PremiumThe Fly
Guggenheim downgrades Incyte on povorcitinib’s ‘somewhat underwhelming’ profile
17d ago
INCY
Incyte downgraded to Market Perform from Outperform at William Blair
PremiumThe Fly
Incyte downgraded to Market Perform from Outperform at William Blair
17d ago
INCY
Incyte downgraded to Neutral from Buy at Guggenheim
PremiumThe FlyIncyte downgraded to Neutral from Buy at Guggenheim
17d ago
INCY
Incyte’s Promising Phase 3 Results and Market Potential Drive Buy Rating
Premium
Ratings
Incyte’s Promising Phase 3 Results and Market Potential Drive Buy Rating
17d ago
INCY
Leerink says Incyte’s povo trial results disappoint, drug likely to be approved
Premium
The Fly
Leerink says Incyte’s povo trial results disappoint, drug likely to be approved
18d ago
INCY
PepsiCo to acquire poppi, Guess receives WHP offer: Morning Buzz
PremiumThe Fly
PepsiCo to acquire poppi, Guess receives WHP offer: Morning Buzz
18d ago
X
TM
Incyte stock decline after results an ‘overreaction,” says Wolfe Research
PremiumThe Fly
Incyte stock decline after results an ‘overreaction,” says Wolfe Research
18d ago
INCY
Incyte could see some weakness as povo looks mostly as expected, RBC says
PremiumThe Fly
Incyte could see some weakness as povo looks mostly as expected, RBC says
18d ago
INCY
Morning Movers: Guess jumps following take-private offer
PremiumThe Fly
Morning Movers: Guess jumps following take-private offer
18d ago
TE
CTM
Buy Rating for Incyte’s Povorcitinib Despite Mixed Trial Results, Highlighting Potential in Biologic-Experienced Subgroups
PremiumRatingsBuy Rating for Incyte’s Povorcitinib Despite Mixed Trial Results, Highlighting Potential in Biologic-Experienced Subgroups
18d ago
INCY
Incyte announces STOP-HS1, STOP-HS2 studies met primary endpoint
Premium
The Fly
Incyte announces STOP-HS1, STOP-HS2 studies met primary endpoint
18d ago
INCY
Opzelura’s Promising Market Potential Despite Trial Inconsistencies: Analyst’s Perspective
Premium
Ratings
Opzelura’s Promising Market Potential Despite Trial Inconsistencies: Analyst’s Perspective
22d ago
INCY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >